PHREESIA INC
PHRNYSE🏆 #2563 by market capEarnings Sep 2US Equity
$12.26▼ $0.01 (−0.08%)
🌅 Pre-market$12.15▼ 0.90%Regular close · extended-hours price shown1h—
24h▼ 0.1%
7d▲ 7.4%
14d▲ 15.6%
30d▲ 14.3%
1y▼ 57.2%
🏦Market Cap
$758M
Small Cap
📈Revenue Growth (YoY)
+14.5%
Healthy
📊Gross Margin
65.8%
High
💵FCF Margin
14.7%
Healthy
⚖️P/S Ratio
1.5x
Cheap
Otter Score
43
Weak
📊
Analyst Ratings
Price
$12.26
Total
25
Raised
1
Lowered
5
Avg PT
$12.17
H / L
$16 / $9
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Truist Securities | Reiterated | Hold | 2026-05-29 | — | — |
DA Davidson | Reiterated | Buy | 2026-05-28 | $14.00 | +14.20% |
Canaccord Genuity | Reiterated | Buy | 2026-05-28 | $16.00 | +30.50% |
Citigroup | Reiterated | Neutral | 2026-05-28 | — | — |
Wells Fargo | Downgraded | Overweight → Equal Weight | 2026-05-20 | $9.00 | −26.60% |
Barclays | Downgraded | Overweight → Equal Weight | 2026-05-15 | $10.00 | −18.40% |
Keybanc | Reiterated | Overweight | 2026-04-13 | $32.00 | +161.00% |
Citizens | Downgraded | Market Outperform → Market Perform | 2026-04-01 | — | — |
JP Morgan | Downgraded | Overweight → Neutral | 2026-03-31 | — | — |
Needham | Reiterated | Buy | 2026-03-31 | $29.00 | +136.50% |
Baird | Downgraded | Outperform → Neutral | 2026-03-31 | — | — |
BMO Capital | Reiterated | Outperform | 2026-03-31 | — | — |
Stephens & Co. | Reiterated | Overweight | 2026-03-31 | — | — |
Mizuho | Reiterated | Outperform | 2026-03-24 | — | — |
JMP Securities | Reiterated | Market Outperform | 2025-09-08 | $34.00 | +177.30% |
Piper Sandler | Reiterated | Overweight | 2025-09-05 | $12.00 | −2.10% |
RBC Capital | Upgraded | Sector Perform → Outperform | 2025-01-08 | $23.00 | +87.60% |
Raymond James | Reiterated | Outperform | 2024-03-15 | $33.00 | +169.20% |
Guggenheim | Reiterated | Buy | 2023-03-29 | — | — |
SVB Leerink | Reiterated | Outperform | 2023-01-05 | — | — |
Berenberg | Reiterated | Buy | 2021-06-08 | — | — |
KeyBanc | Reiterated | Overweight | 2021-03-31 | $32.00 | +161.00% |
Cantor Fitzgerald | Reiterated | Overweight | 2020-01-09 | $70.00 | +471.00% |
Piper Jaffray | Reiterated | Overweight | 2019-08-12 | — | — |
Chardan Capital | Reiterated | Buy | 2019-07-23 | — | — |
Institution
Truist Securities
Reiterated · Hold · 2026-05-29
—
—
DA Davidson
Reiterated · Buy · 2026-05-28
$14.00
+14.20%
Canaccord Genuity
Reiterated · Buy · 2026-05-28
$16.00
+30.50%
Citigroup
Reiterated · Neutral · 2026-05-28
—
—
Wells Fargo
Downgraded · Overweight → Equal Weight · 2026-05-20
$9.00
−26.60%
Barclays
Downgraded · Overweight → Equal Weight · 2026-05-15
$10.00
−18.40%
Keybanc
Reiterated · Overweight · 2026-04-13
$32.00
+161.00%
Citizens
Downgraded · Market Outperform → Market Perform · 2026-04-01
—
—
JP Morgan
Downgraded · Overweight → Neutral · 2026-03-31
—
—
Needham
Reiterated · Buy · 2026-03-31
$29.00
+136.50%
Baird
Downgraded · Outperform → Neutral · 2026-03-31
—
—
BMO Capital
Reiterated · Outperform · 2026-03-31
—
—
Stephens & Co.
Reiterated · Overweight · 2026-03-31
—
—
Mizuho
Reiterated · Outperform · 2026-03-24
—
—
JMP Securities
Reiterated · Market Outperform · 2025-09-08
$34.00
+177.30%
Piper Sandler
Reiterated · Overweight · 2025-09-05
$12.00
−2.10%
RBC Capital
Upgraded · Sector Perform → Outperform · 2025-01-08
$23.00
+87.60%
Raymond James
Reiterated · Outperform · 2024-03-15
$33.00
+169.20%
Guggenheim
Reiterated · Buy · 2023-03-29
—
—
SVB Leerink
Reiterated · Outperform · 2023-01-05
—
—
Berenberg
Reiterated · Buy · 2021-06-08
—
—
KeyBanc
Reiterated · Overweight · 2021-03-31
$32.00
+161.00%
Cantor Fitzgerald
Reiterated · Overweight · 2020-01-09
$70.00
+471.00%
Piper Jaffray
Reiterated · Overweight · 2019-08-12
—
—
Chardan Capital
Reiterated · Buy · 2019-07-23
—
—
One row per institution · price target from the firm's latest published target